Korea

MARKETS

Explore Our APAC Markets

The healthcare sector in Asia Pacific is rapidly growing. As part of the world’s leading Italian biopharmaceutical company, Menarini AP has a strong presence in 13 key markets across the region.

As a partner of choice for numerous global healthcare companies, we engage in the entire pharmaceutical development lifecycle to tap growth opportunities and grow their brand footprint. In doing so, we also support healthcare professionals and patients with quality medical products and technology to raise standards and invigorate lives for tomorrow.

Our APAC Headquarters

A. MENARINI ASIA-PACIFIC HOLDINGS PTE LTD
A. MENARINI ASIA-PACIFIC PRIVATE LIMITED
A. MENARINI SINGAPORE PTE LTD
A. MENARINI BIOMARKERS SINGAPORE PTE LTD

30 Pasir Panjang Road,
Mapletree Business City,
#08-32 Singapore 117440
Tel: +65-6494-7200
Fax: +65-6999-1787

Korea

Who We Are

Menarini Korea is a market leader in the key therapeutic areas of Cardiovascular, Oncology, Urology and Consumer Health. Our team of over 120 employees drive clinical development, regulatory approval, market access, pharmacovigilance, product launches and lifecycle management – operating throughout the commercial value chain in support of the world’s leading bio-pharmaceutical companies.

Armed with global resources and local customer insights, we serve hospitals, healthcare providers and consumers with the best medical innovations and quality solutions to enhance the country’s healthcare. Since establishing our presence in Korea on 1 March 2013, we have amassed a diverse portfolio of proprietary and partnered brands and enjoy steady growth. Leveraging license partnerships as well as research and development efforts, Menarini Korea is committed to increasing its pipeline of innovative medical solutions to bridge healthcare needs throughout the country.

Therapeutic Areas

In building strategic partnerships, we tap our deep expertise to offer our partners tailor-made solutions as well as access to key markets across Asia Pacific. At the same time, our dynamic omnichannel capabilities present multiple opportunities and avenues to expand our reach and realise the full potential of our portfolio. Members of the public are advised to consult a healthcare professional before commencing use of any of our products.

Cardiovascular

Men’s Health

Oncology

Consumer Health

This is Bae HanJoon, CEO of Menarini Korea. Welcome to the Menarini Korea website.

Menarini is a global pharmaceutical company with more than 135 years of history, headquartered in Italy, and is actively present in over 140 countries around the world, including Korea. As the Korean subsidiary of Menarini Asia-Pacific, Menarini Korea has been steadily advancing in the domestic market for the past 11 years by launching a variety of products in the fields of prescription drugs such as cardiovascular disease, men's health, and cancer pain management, and over-the-counter drugs such as Dermatix and Fulcare.

With the vision of “Health, our commitment for life,” Menarini Korea will continue to explore various opportunities to positively impact the lives of patients, and uphold social responsibility and ethical management in business. We promise to do our best to create a healthier tomorrow.

Bae HanJoon,
General Manager

CSR

We have identified the following pillars under the UN Sustainable Development Goals (UN SDG). Together, these reflect our community’s most urgent needs and anchor our drive for greater sustainability.